Literature DB >> 15571812

SUMO protein modification.

R Jürgen Dohmen1.   

Abstract

SUMO (small ubiquitin-related modifier) family proteins are not only structurally but also mechanistically related to ubiquitin in that they are posttranslationally attached to other proteins. As ubiquitin, SUMO is covalently linked to its substrates via amide (isopeptide) bonds formed between its C-terminal glycine residue and the epsilon-amino group of internal lysine residues. The enzymes involved in the reversible conjugation of SUMO are similar to those mediating the ubiquitin conjugation. Since its discovery in 1996, SUMO has received a high degree of attention because of its intriguing and essential functions, and because its substrates include a variety of biomedically important proteins such as tumor suppressor p53, c-jun, PML and huntingtin. SUMO modification appears to play important roles in diverse processes such as chromosome segregation and cell division, DNA replication and repair, nuclear protein import, protein targeting to and formation of certain subnuclear structures, and the regulation of a variety of processes including the inflammatory response in mammals and the regulation of flowering time in plants.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15571812     DOI: 10.1016/j.bbamcr.2004.09.021

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  94 in total

Review 1.  Cardiac function and disease: emerging role of small ubiquitin-related modifier.

Authors:  Jun Wang
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2010-12-31

2.  HIF-1α SUMOylation affects the stability and transcriptional activity of HIF-1α in human lens epithelial cells.

Authors:  Xiao Han; Xin-Ling Wang; Qin Li; Xiao-Xuan Dong; Jin-Song Zhang; Qi-Chang Yan
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-04-16       Impact factor: 3.117

3.  The role of post-translational modifications of huntingtin in the pathogenesis of Huntington's disease.

Authors:  Yan Wang; Fang Lin; Zheng-Hong Qin
Journal:  Neurosci Bull       Date:  2010-04       Impact factor: 5.203

4.  Distinct functional domains of Ubc9 dictate cell survival and resistance to genotoxic stress.

Authors:  Robert C A M van Waardenburg; David M Duda; Cynthia S Lancaster; Brenda A Schulman; Mary-Ann Bjornsti
Journal:  Mol Cell Biol       Date:  2006-07       Impact factor: 4.272

5.  Ubiquitin-family modifications of topoisomerase I in camptothecin-treated human breast cancer cells.

Authors:  Ragu Kanagasabai; Shujun Liu; Samir Salama; Edith F Yamasaki; Liwen Zhang; Kari B Greenchurch; Robert M Snapka
Journal:  Biochemistry       Date:  2009-04-14       Impact factor: 3.162

6.  SUMOylation attenuates sensitivity toward hypoxia- or desferroxamine-induced injury by modulating adaptive responses in salivary epithelial cells.

Authors:  Ha-Van Nguyen; Jo-Lin Chen; Jenny Zhong; Kwang-Jin Kim; Edward D Crandall; Zea Borok; Yuan Chen; David K Ann
Journal:  Am J Pathol       Date:  2006-05       Impact factor: 4.307

7.  Cross-talk between sumoylation and phosphorylation in mouse spermatocytes.

Authors:  Yuxuan Xiao; Benjamin Lucas; Elana Molcho; Margarita Vigodner
Journal:  Biochem Biophys Res Commun       Date:  2017-04-20       Impact factor: 3.575

8.  Inhibition of CDK1 activity by sumoylation.

Authors:  Yuxuan Xiao; Benjamin Lucas; Elana Molcho; Tania Schiff; Margarita Vigodner
Journal:  Biochem Biophys Res Commun       Date:  2016-08-10       Impact factor: 3.575

9.  Structure of a SUMO-binding-motif mimic bound to Smt3p-Ubc9p: conservation of a non-covalent ubiquitin-like protein-E2 complex as a platform for selective interactions within a SUMO pathway.

Authors:  David M Duda; Robert C A M van Waardenburg; Laura A Borg; Sierra McGarity; Amanda Nourse; M Brett Waddell; Mary-Ann Bjornsti; Brenda A Schulman
Journal:  J Mol Biol       Date:  2007-04-10       Impact factor: 5.469

10.  Autoubiquitination of BCA2 RING E3 ligase regulates its own stability and affects cell migration.

Authors:  Yutaka Amemiya; Peter Azmi; Arun Seth
Journal:  Mol Cancer Res       Date:  2008-09       Impact factor: 5.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.